Financial Institutions Raise Price Targets for Medtronic, Spotify, and Corteva

Key Facts

1Robert W. Baird increased Medtronic (MDT) price target to $93.00, maintaining a neutral rating.

2KeyCorp raised Spotify (SPOT) price target to $745.00 following strong quarterly earnings that beat EPS and revenue estimates.

3Mizuho increased Corteva (CTVA) price target to $94.00 with an outperform rating, despite a recent revenue miss.

Several major financial institutions have revised their price targets upward for key NYSE-listed companies, reflecting optimism in their individual performance trajectories. Robert W. Baird increased its price target for Medtronic (MDT) to $93.00 while maintaining a neutral rating. In the tech and entertainment sector, KeyCorp raised Spotify's (SPOT) price target to $745.00 following robust quarterly earnings that surpassed both revenue and EPS estimates. Additionally, Mizuho boosted Corteva's (CTVA) price target to $94.00 with an outperform rating, supported by fiscal year 2026 guidance despite a recent revenue miss. These revisions indicate sustained analyst confidence and suggest potential upside for these specific equities following their latest fiscal updates. Overall, the adjustments signal a bullish sentiment localized to these specific market players.